Leucocyte and Eosinophil Counts Predict Progression-Free Survival in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated With PD1 Inhibition
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14705
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 25, 2017
Authors
Publisher
Wiley